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ABSTRACT

MAMMARY EPITHELIAL CELL GROWTH ON A THREE-DIMENSIONAL
SCAFFOLD IN AN OPERATING BIOREACTOR

by
Melissa M. DaValle

Mammary epithelial cells are highly efficient secreting cells. With genetic
engineering, the uses of these cells could be endless. Research is being conducted on
these cells to determine their full potential to the biotech industry.
This paper investigates whether bovine epithelial mammary cells can survive in
glutaraldehyde-treated gelatin tubes in an operating bioreactor. Many bioreactors were
developed and tested to suit the needs of the cells. Procedures were created and carried

out to ensure sterility of the bioreactors. Bovine mammary epithelial cells were implanted
in the bioreactors and samples of their growth were taken over time.

iv

ACKNOWLEDGEMENTS

First, I would like to thank everyone in the General Engineering Department for helping
me get where I am today. I would especially like to thank Dr. Crockett for his guidance
throughout this project. I also would like to thank Danielle, Mollie, Chris, and Dr.
Peterson for their support on this project as well.
Additionally, I would like to thank committee members Dr. Kristen O'Halloran Cardinal
and Dr. Dan Walsh for their cooperation and input on the improvement of this thesis.

Furthermore, everyone at Cal Poly – friends, faculty, and staff – have made an impact on
me that I will never forget.
My true gratitude goes to Mark, without whom I wouldn’t have finished this paper. His
undying support has and always will mean the world to me.

v

TABLE OF CONTENTS

LIST OF TABLES............................................................................................................ vii
LIST OF FIGURES ......................................................................................................... viii
CHAPTER
I. INTRODUCTION ............................................................................................................1
Mammary Cells and Their Function ........................................................1
Tissue Engineering...................................................................................2
Cell Growth on Substrate.........................................................................5
Bioreactors ...............................................................................................7
II. TUBE STRUCTURE DEVELOPMENT
Materials and Methods...........................................................................10
Results and Discussion ..........................................................................13
III. BIOREACTOR
Materials and Methods...........................................................................15
Results and Discussion ..........................................................................20
IV. CELL SEEDING OF BIOREACTOR
Materials and Methods...........................................................................22
Results and Discussion ..........................................................................26
V. CONCLUSIONS...........................................................................................................29
VI. FUTURE WORK.........................................................................................................30
REFERENCES ..................................................................................................................31
APPENDICES ...................................................................................................................34
A.
Protocols ................................................................................................35
B.
Additional Images of Cells ....................................................................58

vi

LIST OF TABLES
Table 3.1 Table of Bioreactor Designs, with scored requirements (1=poor, 5=exemplary) ........... 20

vii

LIST OF FIGURES
Figure 1.1 Macro and micro view of mammary gland.................................................................... 1
Figure 1.2 Experiment demonstrating the necessity of the ECM .................................................... 4
Figure 1.3 Collagen to gelatin process........................................................................................... 5
Figure 1.4 Bioreactor model.......................................................................................................... 7
Figure 2.1 Valves and a Teflon rod used for tube construction..................................................... 10
Figure 2.2 Autoclaved plastic casting block with 2 layers of sterile tape, ready for gelatin
solution ........................................................................................................................................ 11

Figure 2.3 A dry, untreated gelatin tube wrapped around the Teflon rod-valve apparatus. ............ 12
Figure 2.4 Two views of glutaraldehyde treated gelatin tubes...................................................... 13
Figure 2.5 Weakness in gelatin tube structure.............................................................................. 13
Figure 3.1 General Bioreactor System ......................................................................................... 15
Figure 3.2 Design 1 (a) bioreactor container (b) preliminary sketch of set up of bioreactor .......... 16
Figure 3.3 Design 2: Cell Flask (a) bioreactor housing (b) preliminary model of bioreactor ......... 17
Figure 3.4 Initial prototype for final bioreactor design ................................................................. 18

Figure 3.5 Final bioreactor design .............................................................................................. 19
Figure 4.1 Final bioreactor design ............................................................................................... 23
Figure 4.2 Part A detail ............................................................................................................... 23
Figure 4.3 Part I detail................................................................................................................. 23
Figure 4.4 Gelatin tube placement ............................................................................................... 25
Figure 4.5 Media Exchange ......................................................................................................... 26
Figure 4.6 Two views of mammary call growth on Petri dishes ................................................... 26
Figure 4.7 Mammary cell growth on treated gelatin tubes 2 days after implantation..................... 27
Figure 4.8 Mammary cell growth on treated gelatin tubes one week after implantation ................. 27

viii

Chapter 1: INTRODUCTION
“Biopharming” is the use of transgenic animals, plants, and bacteria to produce
pharmaceuticals. This is an emerging field, with new advances occurring frequently.
Pharmaceuticals produced by genes inserted into living things are an innovative idea, but
can be difficult to perfect in practice. Mammary tissue is ideal for biopharming because
of the ability to secrete, but the genetic engineering of mammals is expensive. Working
with the cells in vitro reduces the possibilities of outside interactions affecting the system.
This paper’s emphasis is to determine if bovine epithelial mammary cells survive in
glutaraldehyde-treated gelatin tubes in an operating bioreactor.
MAMMARY CELLS AND THEIR FUNCTION
A mammary cell is a specific epithelial cell with the ability to secrete milk
proteins. Figure 1.1 depicts an individual alveolus and a gland. The mammary cells line
the lumen of the alveolus.

Figure 1.1 Macro and micro view of mammary gland [12]
The alveolus is then surrounded by myoepithelial contractile cells that aid in the
movement of the milk proteins from the lumen to the ducts. The alveoli are all connected
by a system of ducts to form a lobule. The lobules form a lobe, which combine to make
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the mammary gland. The milk is produced when the hormone oxytocin is released
causing the epithelial cells to produce milk products (casein micelles, lactose, fat lobules,
etc.). The milk then flows from the glands through ducts to the nipple [12].
The epithelial cells lining the lumen are polar by nature, meaning the opposing
sides of the cell serve very different functions. This polarization must be present for the
gland to function properly. Nutrients are taken in by one side and milk proteins are
secreted from the other. The inside of the cell is polarized in a similar way with the
nucleus on the basal (blood) side, accepting nutrients, and the contents responsible for the
milk production on the apical (lumen) side [7]. The basal membrane is very important
because it provides the structure for the alveoli and lobes. The extracellular matrix
(ECM) is vital for holding the cells in place - promoting the functional and structural
characteristics of the cells [5].
It is very important for the cell environment to be replicated in vitro. The
geometry and scaffolding should mimic the in vivo conditions as much as possible. To
make this possible, the basal and lumen sides of the cells must be recreated with nutrients
on the outside and a simulated lumen space internally. This should provide the cells with
the structure to secrete as they would normally.
TISSUE ENGINEERING
Tissue engineering is a rapidly evolving discipline that seeks to repair, replace, or
regenerate specific tissues or organs by translating fundamental knowledge in physics,
chemistry, and biology into practical and effective materials, devices, systems, and
clinical strategies [11]. Tissue engineering is traditionally thought to focus on the
development of in vitro bioartificial tissues, which are typically based on cells derived
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from donor tissue. The tissues can be used as transplants to improve biological function
of the recipient. Typical tissues include skin, liver, pancreas, kidney, blood vessels, and
bone. If done in vivo, local modifications are performed to alter cell growth and function
[15].
Tissue engineering is the duplication of tissue, whereas protein production uses
one particular cell type for producing specific proteins. Transfection is the introduction
of foreign DNA into higher organisms, classifying them as transgenic animals. The
animals are engineered to express a specific protein, releasing it into specific fluids such
as milk or urine. This process is cost effective for complex proteins, but has unfavorable
health effects for the host animal [15]. Another problem that can occur is that the
posttranslation of the protein is not always complete, incurring more cost. Eliminating
the effects to the animal and isolating the production zone increases the likelihood of the
biologic system to persist. Mammalian cells grow slower, have more expensive media,
and have lower protein expression than microbial growth, causing them to be more
expensive overall. Mammalian cell culture is chosen when the virtual authenticity of the
product protein must be complete [15].
Anchorage-dependent cells must spread on a substrate to proliferate and function.
Most animal cells must attach to a surface to resume normal growth, and resume the
three-dimensional environment [4]. Cell adhesion is mediated by extracellular matrix
(ECM) proteins. The ECM has nonspecific cell surface receptors which facilitate
adhesion; cell binding is more successful if specific receptors are present [15]. The ECM
may contact the cells only at one surface, as is the case with epithelial and endothelial
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cells, or it may completely surround cells like chondrocytes. ECM components regulate
differentiation and development of cells.

Figure 1.2 Experiment demonstrating the necessity of the ECM [3]
As seen in Figure 1.2, fibronectin (a component of the ECM) is necessary for the cell to
survive and proliferate. Mammary epithelial cells assume the polarized phenotype and
secrete milk proteins in vitro when cultured on reconstituted basement membrane or
collagen gels [1]. Due to the critical nature of the ECM for cell function, a well-designed
scaffold needs to be created to support the cells.
Three-dimensional porous scaffolds promote new tissue formation. They do this
by providing a surface and void volume that promotes attachment, migration,
proliferation, and desired differentiation of connective tissue progenitors throughout the
region where new tissue is needed [11]. Several requirements have been identified as
crucial for the production of tissue engineering scaffolds: (1) scaffolds should possess
interconnecting pores to favor tissue integration and vascularization, (2) have appropriate
surface chemistry to favor cellular attachment, differentiation, and proliferation, (3)
possess adequate mechanical properties to match the intended site for implantation and
handling, (4) be made from a biodegradable or bioresorbable material, that degrades at an
appropriate rate with no undesirable byproducts, so that the tissue will eventually replace
the scaffold, (5) be easily fabricated into a variety of shapes and sizes [13, 14].
4

Scaffolds are currently being made with a wide variety of materials: biological
polymers, synthetic polymers, tissue-derived materials, ceramics or mineral-based
matrices, metals, and composites of two or more materials [11, 13]. Collagen may be the
ideal scaffold material as it is the major component of the ECM. It provides a more
native surface, relative to synthetic polymers, favoring cellular attachment as well as
being chemotactic to cells. Also, collagen substrates can modify the morphology,
migration and in certain cases, the differentiation of cells. Collagen is relatively easy to
fabricate into structures using freeze-drying and critical point drying techniques [14].
Other scaffold fabrication techniques include gas foaming, fiber bonding, melt molding,
and solution casting [13].
CELL GROWTH ON SUBSTRATE
Gelatin is derived from collagen. Collagen is tightly coiled polypeptide chains
formed into a triple helix. The collagen goes through the process of hydrolysis to
Figure 1.3 Collagen to gelatin process [17]

degrade it into gelatin. Collagen is very strong and is present in most connective tissues
and support structures. Gelatin is essentially a weakened form of collagen, in that it is
denatured into a matrix of the single strands of collagen [9, 17]. Figure 1.3 illustrates the
collagen and gelatin structures. Gelatin is not nearly as strong as collagen, but it has its

5

own advantages, the most important of which being added flexibility. Collagen is a
naturally occurring substance; therefore it, as well as gelatin, are biocompatible and can
be used as a scaffold in tissue engineering [10].
Gelatin in its natural state would degrade in the 37°C environment that is required
to support mammary cells. The gelatin needs to be strengthened to survive. The way to
do this safely, with little residual affects, would be to use glutaraldehyde. Glutaraldehyde
is an organic compound that is used as a covalent cross-linking agent [15]. When it is
used to cross-link collagenous tissues, biodegradation is reduced and strength and
flexibility are preserved [8, 18]. Glutaraldehyde is advantageous in that it works quickly
and reacts with a large amount of amino acids, resulting in a more tightly cross-linked
network. It is also less expensive, readily available, and is highly soluble in aqueous
solution. Glutaraldehyde can be crosslinked with collagen, resulting in a more stable
matrix compared to other aldehydes. Glutaraldehyde also acts as a sterilant, showing
resistance to bacteria and fungi. Gelatin treated with glutaraldehyde is known to support
cell growth with no adverse effects on cell morphology or growth. After treatment, the
gelatin must be thoroughly rinsed, eliminating any cytotoxic effects [8].
The structure of the treated gelatin needs to be similar to the extracellular matrix
(ECM) of the cell [14]. The ECM provides support, protection, and also aides in
communication between cells. Creating a stable three-dimensional structure similar to
the in vivo environment is essential for cell proliferation and vital to the functionality of
the cells. The thickness of the matrix plays a large role as well, in that a thin matrix is
less durable and a thick matrix has limited diffusion [15]. A tube configuration of a thin
gelatin film provides the 3D structure for the cells and allows for the movement of
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nutrients [2]. The tube structure, along with defined, controlled surroundings simulates
the in vivo environment needed to survive.
BIOREACTORS
A bioreactor is a device used to generate a product using a biological system. The
graphic below (Figure 1.4) illustrates the general form of a bioreactor system [6]. This
model illustrates the different factors which influence the performance of a bioreactor.

Figure 1.4 Bioreactor model
According to the article Flow Modeling in a Novel Non-Perfusion Conical Bioreactor, an
ideal bioreactor has the following functions: (A) establish a uniform distribution of cells
on a three-dimensional scaffold; (B) maintain the desired concentration of gases and
nutrients in the culture medium; (C) provide efficient mass transfer to the growing tissue;
(D) expose developing tissue to physical stimuli; (E) ease of usability, maintenance, and
sterilization and (F) provide information regarding the formation process of 3D tissues,
which originate from the isolated cells; (G) be cost effective with respect to up-scaled
designs [16]. Most bioreactors can meet many of these functions, but it is difficult to
optimize each category, especially with regards to the cost effectiveness.
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Bioreactors provide an environment that stimulates the growth of mammalian,
bacterial, fungal, and yeast cells to produce a specified product. Homogeneity in regards
to temperature, pH, and nutrients can be simulated within a bioreactor, allowing cells to
thrive [4]. There are many types of bioreactors, but only a few are used with mammalian
cells. Animal cells have no cell wall; therefore they are more fragile and are sensitive to
the shear forces inside a bioreactor. This also complicates the design of large-scale
bioreactors for animal cells. Animal cells also require much less oxygen compared to
plant and microbial cells, therefore less aeration is needed [15]. Cells can be grown in
suspension or immobilized on walls or scaffolds.
With animal cells, immobilization is beneficial because it reduces the need to
filter out cells post-production, more cells will be produced, as well as the fact that
immobilized cells can carry out production of more complex products. Immobilization
has its drawbacks in that it is difficult to control the microenvironments of the cells and
the product needs to be secreted by the cell. Diffusion limitations are also a concern in
that cells may be overcrowded, depriving themselves of nutrients. In addition, diffusion
may be difficult if the actual surface the cells are growing on has limited porosity [15].
Diffusion is vital to deliver nutrients to the cells, but it also plays an important role in
delivering the product.
Once a product has been secreted or produced by a cell, post-production work
must be completed. Depending on the cell and product, a wide variety of processes may
need to be completed to obtain the product. Products may include the biomass itself or
an extracellular or intracellular component.
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Depending on the intended use of the product, a high level of purity may be
required. Most mammalian products are extracellular and soluble. For example,
antibiotics and enzymes are two products that commonly exhibit those features.
Processes used to recover these include extraction, adsorption, ultrafiltration, and
chromatography. Proteins need to be separated slightly differently in that organic
solvents or salts may need to be added to precipitate out from the media. For any
product, drying, and possibly crystallization, will need to occur [15]. Animal cells
produce proteins that usually do not need further alteration besides purification because
of their ability to process the complex proteins. Purification is complex because the other
protein by-products generated by the cells are intermixed with the product of interest.
Additionally, the serum from the growth media is an inexact mixture of nutrients and
proteins that need to be extracted. The required purity makes a large impact on how long
a product will take to process, as well as how much it will cost to produce.
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Chapter 2: TUBE STRUCTURE DEVELOPMENT
The tube structure is vital for the cell bioreactor system to work properly. It must
be stable enough for cell adhesion and it needs to be able to maintain its structure in the
fluid environment. It also needs to have a porous surface for diffusion, which is one of
the reasons gelatin was chosen for this system.
MATERIALS AND METHODS
Previous work was done to find what the best concentration of gelatin would be
for the tubes. In earlier research, it was found that either a 5% or 7% concentration of
gelatin (to MilliQ water) would be the best to work with. Those concentrations provided
sheets that were not too brittle to handle and dried into an even surface. The original
gelatin films were cast into squares (30 cm x 30 cm) with 1 milliliter of gelatin solution
in each square.
It was found the squares would provide too much overlap for the existing parts
that were going to be used in the bioreactor. The existing parts for the bioreactor are seen
in Figure 2.1 below. A Teflon rod provides a base structure for the two valves, and
allows for tube assembly.

Figure 2.1 Valves and a Teflon rod used for tube construction
The circumference of the valves was about .39” or 1 cm. The width of the tube needed to
have a slight overlap for construction purposes, which led to the use of a 2 cm width.
That was later revised to 1.8 cm to reduce the overlap to ensure proper diffusion could
take place. The width could not be reduced much more because it would be difficult
constructing the tubes. The length was found to be a maximum of 4.5 cm because of the
bioreactor constraints; which was later revised to 4.0 cm. The gelatin films were cast on
10

autoclaved polycarbonate blocks that were aseptically assembled in the hood with 2
layers of sterile tape (Figure 2.2).

Figure 2.2 Autoclaved polycarbonate casting block with 2 layers of sterile tape, ready for gelatin
solution

The previously found baseline for the gelatin was used to find the new amount of solution
to use (0.8 mL) per square.
Baseline →

900 mm2 = area of section (in mm2)
1 mL
new volume

It was decided that one of the two gelatin concentrations needed to be selected to provide
consistency for the rest of the experiment. The 7% gelatin concentration was selected
because it was slightly easier to work with; it seemed to be more durable. The complete
protocol for creating untreated gelatin sheets (for the tubes) can be found in Appendix A.
The actual tube assembly process is a critical step in the process of creating the
bioreactor system and needs to be done very carefully. Once the sheets (40mm x 18mm)
are dry, they are ready to be formed into a tube. The sheets need to be rehydrated which
causes them to be susceptible to tearing because they have not yet been treated with
glutaraldehyde. The tubes need to be formed with as few air bubbles as possible and with
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a tight seal around the valves. If the seal is not tight from the beginning, the cells will
most likely leak out. Once the gelatin sheets are placed around the autoclaved Teflon
rod-valve apparatus, complete drying of the tubes is necessary otherwise the structure
may come apart during the treatment phase. Figure 2.3 shows a dry untreated gelatin
tube.

Figure 2.3 A dry, untreated
gelatin tube wrapped around the
Teflon rod-valve apparatus.

The complete protocol for rolling the untreated gelatin sheets into tubes can be found in
Appendix A.
The next step for creating the gelatin tubes that are to be placed in the bioreactor
would be the glutaraldehyde treatment. The treatment creates the cross-linking necessary
for the gelatin to survive in the 370C environment as well as provides an extra step of
sanitation. Particular concentrations of glutaraldehyde, 0.1% or 0.3%, were previously
determined as viable. A detailed protocol was also created for treating gelatin films, but
it was determined that treating the gelatin in tube form would be the better method. The
treatment process is long, ranging from 9 to 10 hours depending on how many items are
being treated. The process has a short time period (20 minutes) of exposure to the
glutaraldehyde solution, with the rest of the time spent rinsing the glutaraldehyde from
the apparatus and gelatin. The whole process uses agitation to ensure complete removal.
If there is any residual glutaraldehyde on the gelatin tube, the mammary cells will be
destroyed. Once the tubes have dried for at least 24-48 hours, the Teflon rod needs to be
removed. The gelatin is still brittle even though it has been treated with glutaraldehyde,
so the rod needs to be removed carefully. If the tube is not completely dry, the gelatin
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will have too much friction with the Teflon rod and will tear. The treated gelatin tube,
with the Teflon rod removed can be seen in Figure 2.4 below. The complete protocol for
treating the gelatin tubes in glutaraldehyde can be found in Appendix A.

Figure 2.4 Two views of glutaraldehyde
treated gelatin tubes.

RESULTS AND DISCUSSION
Placing the gelatin film around the Teflon rod-valve apparatus is one of the best
options for the gelatin tube because it provides a consistent amount of material
throughout the whole tube. Also, it is easier than trying to build a three-dimensional tube
with no support structure. One of the biggest difficulties and weaknesses of placing the
gelatin film around the tube is the seam around the valves (denoted by the arrow in
Figure 2.5 below).

Figure 2.5 Weakness in gelatin tube structure
Once the treated gelatin tube (with the rod removed) becomes moist and filled with fluid,
the pressure may cause a leak. If the gelatin sheet was placed correctly, leaks will likely
not occur. The treated tube, when moist, is actually more durable than when dry; it has
some give and take and is almost elastic in nature. The glutaraldehyde breaks down the
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gelatin over time so a two-week shelf life was determined to be the limit. No testing was
done to establish the exact time of decay, but it was done as a precaution.
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Chapter 3: BIOREACTOR
The treated gelatin tubes need an environment that will allow for cell survival.
Several criteria had to be met for the system to work:
-

Holes needed for gas exchange

-

Smallest amount of moving the gelatin tube as possible

-

Sterile environment

-

Small storage area for media, limits how much media is used at one time

-

Fluid in/out for surrounding media

-

Fluid in/out for gelatin tube

-

Hold the predetermined tube-valve structure

MATERIALS AND METHODS
Three bioreactor designs were considered for the experiment. All the above
criteria needed to be met in some capacity. Each design was then evaluated based on
how well it would fulfill the criteria (see Table 3.1 in the next section). Figure 3.1 shows
the basic system for the bioreactor. The simplified picture shows ports for the media to
be exchanged from the system, as well as a way for the cells to be inserted and the saline
solution to be circulated.

Figure 3.1 General Bioreactor System
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The first design was a plastic container with lid. The container looked similar to
that of the one in Figure 3.2(a) and had a capacity of 500 milliliters. Figure 3.2(b) is a
sketch of how the container would be modified to perform as a bioreactor. Holes were to
be drilled in the top and some sort of structure was to be provided for the tube to sit in.

(a)
(b)
Figure 3.2 Design 1 (a) bioreactor container (b) preliminary sketch of set up of bioreactor
This design was quickly eliminated for many reasons. The capacity was too large;
changing the media would mean using at least 200 mL of media every 3-4 days. If a
smaller container was used, the problem created was that building a structure for the tube
to sit in with the ability to have an in/out mechanism increases in difficulty.
Additionally, a pump would probably be necessary to get fluid flow through the gelatin
tube. One positive to this design would have been the removable lid because it would
have allowed for easier assembly; however the drawbacks of this design outweighed this
positive aspect.
The next design that was considered used a cell flask for the bioreactor. Several
varieties of flasks were researched, but a basic tissue culture flask from Techno Plastic
Products (TPP) with a re-closable lid was thought of for the next bioreactor design
possibility. The flask from TPP is shown in Figure 3.3(a) and a mock up of the
bioreactor for the cell flask is pictured in 3.3(b).
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The tissue culture flask in Figure 3.3(b) is a general flask (with similar
dimensions) that had the top layer of plastic removed, and is not the flask from TPP. The
cell flask model was also dismissed after further examination for several reasons:

Figure 3.3 Design 2: Cell Flask
(a) bioreactor housing (b) preliminary
model of bioreactor

(a)

(b)
There was a concern that for the media to completely cover the gelatin tube, the cell flask
would need to be at a maximum capacity or more. The capacity for the flask is 100 mL,
which did not provide a substantial reduction from the previously considered design.
Another concern was that the lid to the flask would need to be altered to allow a tube to
run through. The lids are specifically designed for gas exchange and altering them might,
in turn, alter the functionality of the system. Attempts to drill holes for the in/out tubing
showed that the plastic was prone to cracking. A single crack would ruin the flask and a
new one would need to be constructed. The shape of the flasks would allow the flasks to
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stack during storage. That advantage, as well as the removable lid (for assembly
reasons), were great assets, but the limiting factor was the capacity of the flask.
The final design proved to be the best. The base of the bioreactor is a 50 mL
Falcon tube. Holes were drilled in the lid and through the bottom for the tubing to run
through. Right away this seemed to be the best design because of the limited amount of
media it needed. Using the Falcon tube also gave the advantage of an inexpensive base,
which would allow for easy modifications, thus limiting the worry and expense created
by mistakes during the construction process. This design also had the advantage of using
gravity for the media exchange. Figure 3.4 is a photo of one of the initial prototypes for
the final design.

Figure 3.4 Initial prototype for final bioreactor design
The initial prototype was fairly easy to manufacture which would mean many could be
produced for use at one time. Some aspects of the initial design showed cause for
concern. For example, the bottom of the bioreactor was sealed was by pulling the tubevalve connection tight, creating a compression seal. The gelatin tube was inserted prior
to creating this seal. This puts strain on the gelatin tube, which could lead to breaking it;
some method should be determined to reduce the strain. Another feature, or features, that
needed to be added was for the media exchange. Ideally, the media exchange should
disturb the gelatin tube the least amount possible. Seeding of the mammary cells into the
gelatin tubes is the most important part of the process because, without the cells, the
18

bioreactor is useless. Chapter 4 will focus on general cell seeding and media as well as
the specifics for the bioreactor.
The initial prototype needed a lot of work to become a functional bioreactor.
There needed to be holes for gas exchange, and the lid was deemed to be the most
appropriate place. Small holes were drilled around the top. Because of this, the
bioreactor would need to be vertical so a test tube rack was used to hold the bioreactors in
place. It was also decided there would be two valves on the bioreactor, one above the
media level and one at the bottom to be used for media exchange. An IV clamp was
added onto the lower tube because of the cell seeding (discussed in Chapter 4 along with
detailed description of bioreactor). Figure 3.5 shows a fully assembled bioreactor ready
for sterilization and then cell seeding.

Figure 3.5 Final bioreactor design
There were still concerns with the leaking and the fragility of the gelatin tubes, but by
carefully following the proper procedures, there would be few problems. Aspects of the
final design were discussed with Christopher Heylman, who wrote a detailed paper on the
final bioreactor design. He also created protocols for bioreactor assembly, bioreactor
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sterilization, cell seeding of the bioreactor, and media exchange of the bioreactor. The
revised protocols used in this case can be found in Appendix A.
RESULTS AND DISCUSSION
The three designs fulfilled the needs in different ways. Some of the designs met
more of the needs than others. The needs were: holes for gas exchange, smallest feasible
amount of movement of the gelatin tube, sterile environment, a small storage area for
media, fluid in/out for surrounding media, fluid in/out for gelatin tube, and to be able to
hold the predetermined tube-valve structure. Another thing that became important was
the ease of the assembly process. Table 3.1 below shows a summary of the three designs.
Table 3.1 Table of Bioreactor Designs, with scored requirements (1=poor, 5=exemplary)
Bioreator
Design
Design 1
Cell Flask
Falcon Tube

Fluid
Capacity
1
2
5

Approximate
Size
1
2
4

Gas
Exchange
2
2
4

In/out
Capacity
1
2
4

Usability
4
2
3

Average
Score
1.8
2.0
4.0

The table shows the most important requirements and each design’s respective
performance on a scale from 1 to 5, 1 being poor and 5 being exemplary, to evaluate each
of the designs. The first design had a high rating in usability, meaning how easy it would
be to manufacture and use with the gelatin tubes. It was never fully built, but the
speculation was that the lid would make it easy to move around and assemble. The
design did not do very well with the other important aspects, giving it an average score of
a 1.8. The cell flask design also scored below what was preferable for the bioreactor in
every category causing us to look for a more complete design. This led us to the final
design using the Falcon tube. The fluid capacity scored high because to fit all the tubing
and valves into one place, the area was just the right size. If the space was smaller,
everything might not have fit as well. The usability is not very high because of the
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aseptic cell seeding process (see Chapter 4), but the Falcon Tube design outscored the
other two designs and met the needs we felt were most important.
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Chapter 4: CELL SEEDING OF BIOREACTOR
The next step in the process was to merge the mammary cells with the bioreactor.
The mammary cells needed to be grown separately in Petri dishes and then implanted into
the gelatin tube in the bioreactor.
MATERIALS AND METHODS
The first step in the seeding of the bioreactors is to grow the mammary cells. A
highly concentrated tube of cells is thawed, diluted, and placed into Petri dishes. The
cells are fed with special media every 2-3 days and kept in an incubator at 370C. The
goal is to grow the cells to confluence, which then allows the cells to be split to make
more plates of cells or, for our purposes, be implanted into the bioreactors. The full
protocol is listed in Appendix A under “Protocol for Plating, Splitting/Passaging, and
Freezing of Cells”.
Various types of media are used for different purposes when used with the cells.
The first type of media, which is the basis for the other types of media and is not directly
added to the cells, is called the basal media. The basal media starts from a powder or
liquid base and MilliQ water. Other ingredients are added and the pH is adjusted to the
optimal level of 7.0 to 7.10. The mixture is then filtered aseptically and placed into an
autoclaved bottle. This basal media can be stored in the refrigerator for a few months and
will be used as the foundation for the other cell medias (see Appendix A for various cell
media protocols).
Other cell media are prepared from the basal media and will be used with cells.
The shelf life for the media is only about two weeks; only small quantities should be
prepared so there is no waste. The first is a basic, regular media that uses the basal media
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and has Fetal Bovine Serum (FBS) and antibiotics added, used for maintaining cells. The
next is a growth media that adds insulin and progesterone to the FBS and antibiotics. The
last type of media is lactation media, which has a hormone that promotes lactation in the
mammary cells. The growth media would be the first to be used in the bioreactor and
once the cells reach confluence in the gelatin tube, lactation media can be added.
The bioreactor needs to be an environment suitable for cell growth, maintenance,
and production. The following is a detailed description of the bioreactor:

Figure 4.1 Final bioreactor design.

Figure 4.2 Part A detail
•

Figure 4.3 Part I detail

Piece A: Lid apparatus (closer image in Figures 4.2 and 4.3)
o Piece G: A syringe filled with cells (discussed later in cell seeding) hooks
onto this and injects cells through the tubing and gelatin tube. This is also
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where fluid is injected to wash out the product from the mammary cells,
once lactation is initiated.
o Piece H: The nut allows for the valve (J) to be screwed tightly in place
with the gelatin tube attached.
o Piece I: The lid holds the valve (J) and has small holes for gas exchange
(Figure 4.3).
o Piece J: One of the valves the gelatin tube clicks into. This part can be
moved up and down with use of the nut to ensure proper fit of the gelatin
tube in the bioreactor.
•

Piece B: Media input valve with cap

•

Piece C: Gelatin tube and media storage space

•

Piece D: Media output valve with cap

•

Piece E: IV clamp used during the cell seeding process

•

Piece F: Tubing and valve through which cell products will be obtained

Once the bioreactor is assembled and sterilized, it is ready for cell seeding. The initial
assembly and sterilization protocols are found in Appendix A.
The next step is to aseptically prepare the bioreactor for seeding the cells. This
includes attaching the treated gelatin tubes and placing the bioreactor in a rack of others.
From this point onward, all procedures are done in the sterile hood with sterile gloves and
extreme caution is taken to keep everything sterile. The gelatin tube is secured into the
bioreactor with forceps, and the tubing (piece F) is pulled putting the gelatin tube in
position for the lid. The lid can now be screwed on, making sure to use the nut for proper
gelatin tube placement (Figure 4.4 depicts this process). The bioreactor is placed in the
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rack and the other bioreactors are to be prepared in the same manner. The bioreactors are
now ready for cell seeding, which should be done immediately following the assembly.

Cell seeding starts with the assembled bioreactor. Mammary cells that have been
grown to confluence are used. Cells are separated from the plastic using trypsin and are
placed in warmed cell growth media. A small sample is taken to count the cells and a
3mL sterile syringe (with needle removed) is filled with cells, screwed on to Piece G and
the plunger is pushed until cells reach the bottom of the gelatin tube. Once the fluid
reaches this point, the IV clamp (Piece E) is clipped shut so the cells will stay near the
gelatin to grow. Warmed growth media is put into a 50mL syringe that is then attached
to Piece B and injected into the bioreactor. The process is repeated for the other
bioreactors. The cells need to be seeded in the bioreactors quickly so no attachment or
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cell death occurs in the falcon tube. The bioreactors are placed into
the incubator at 370C. Media is changed every 3-4 days by draining
the media from Piece D and fresh media is injected with a 50mL
syringe in Piece B (Figure 4.5). The bioreactors are initially used to
test for confluence. The next step would be switching the media
from the growth media to a lactation media and then measuring the
output of the mammary cells.
Figure 4.5 Media exchange
RESULTS AND DISCUSSION
The cell seeding results show that some growth is possible in the bioreactor.
Problems occurred with the bioreactors leaking causing results to be lost. Figure 4.6
demonstrates what mammary cells look like when grown to confluence on regular cell
growth plates (Petri dishes). The cells cover the plate until there are no open spaces.

Figure 4.6 Two views of mammary cell growth on Petri dishes
Previous work has shown mammary cells grow just as easily on the treated gelatin as on
the Petri dishes. Introduction of different geometry might have been what caused
difficulties in the growth of the mammary cells. Only some parts of the gelatin tubes
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seemed to have growth. Figure 4.7 shows two of the pictures of the treated gelatin tubes
cut open two days after mammary cells were implanted in the bioreactor.

Figure 4.7 Mammary cell growth on treated gelatin tubes 2 days after implantation
The next pictures show more gelatin tubes cut open a week after the cells were implanted.
Figure 4.8 Mammary cell growth on treated gelatin tubes one week after implantation

The only presence of anything on the gelatin was seen in Figure 4.8 - possibly cells, but
not likely. The gelatin tubes that were examined at this point all looked similar with no
growth.
There could be many reasons the tubes did not show mammary cell growth. The
first reason could have been a small leak in the gelatin tube. A small leak may not have
been noticed and the cells could have gone into the media. Another possible reason was
that the cells settled in the valve at the bottom of the gelatin tube because of gravity. If
the cells did not get the nutrients they needed, which would be likely if they were in the
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valve, cell death would be inevitable. Other possible reasons for lack of cell growth
could have been the amount of cells implanted, the gelatin wasn’t porous enough, the
toxicity of bioreactor sealant, or a bacterial infection.
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Chapter 5: CONCLUSION
The research completed shows potential in the three-dimensional polarized
environment for the mammary cells. The concept of the mammary cell and bioreactor
system has the ability to be a great asset to the biopharmaceutical industry. Transgenic
animals, another alternative, are expensive and have proven to be difficult to gain
consistent results from. This system provides a much more affordable and reliable
solution to transgenic animals.
The genomic and proteomic research for using mammary glands as protein
production tools is far-reaching. A full-scale system has production potential and even
has the possibility of going into other fields of biotechnology like tissue engineering.
This system may also help with current research of bioreactors, secretion systems, and
living system production. This mimicked living system provides the ability to
manufacture biopharmaceuticals in a factory-like setting. Working with mammary cells
and creating an artificial environment for them to survive, which was the goal of this
project, can aid in the production of complex compounds.
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Chapter 6: FUTURE WORK
Extensive work has optimized the bioreactor environment for the gelatin tube and
mammary cell growth. The ultimate goal of this project is for the mammary cells to
secrete in the bioreactors as they would in vivo. Previous work is promising and provides
confidence in moving on with this project. Many more sets of bioreactors and gelatin
tubes need to be assembled and injected with cells.
A highly concentrated solution of cells would provide a better chance of adhesion
to the gelatin. Once the cells are thriving, the gelatin tube can be flushed with phosphate
buffered saline (PBS) to further induce the polarization needed for the bioreactor system.
The polarization is vital in the secretion process because the PBS will be collecting the
results and the cells will have the nutrients to sustain life only on the basal side (outside
of tube).
The next step in the process would be to switch from growth media to lactation
media, inducing secretion. The mammary cells should start producing milk, which can
then be measured by testing for the presence of lipids. Lipid production may be difficult
to measure because of the relatively small amount that the cells secrete, so running the
PBS through the bioreactor system multiple times should increase the concentration. The
production from the bioreactor should be compared to the production of the cells in a
similar sized gelatin environment to see if there is a drastic difference in production. If
little growth continues to occur, toxicity tests should be done on the glue used on the
seals of the bioreactor.
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Protocol for Mixing, Casting/Taping Gelatin Sheets
***Casted films last approximately 2 weeks.
Materials:
Masking tape (Staples brand)
Autoclaved Plastic casting blocks/plates
300 Bloom Type A Gelatin (Sigma G1890-500g)
Sterile (autoclaved) Milli Q water
Sterile (autoclaved) pipettor
Sterile pipette tips
Method:
All steps (except 2-4) must be done inside the sterile hood.
**Make sure to ethanol your gloves and wipe down the hood, as well as wipe off anything to
be put in the hood with a Kimwipe soaked in ethanol, every time you enter the hood.
1. Using masking tape (that has been opened and kept inside the hood), mask off
segments on a sterilized autoclaved plastic plate. Tape top and bottom of segments
first using 2 layers of tape. Then tap the sides of the segments using 2 layers of tape
(This is easier to remove once films are dry). Once finished taping, label each casting
block with what gelatin concentration you are casting, your initials and date.
Sizes:
Films for diffusions – 30mm x 30 mm, use 1mL of gelatin solution for casting per
square
Tubes – 40mm x 18mm, use 0.8mL of gelatin solution for casting per rectangle
Calculations for amount to pipette:
Baseline → 900 mm2 = area of section (in mm2)
1 mL
new volume
2. Heat 10mL** of sterile Milli Q water in autoclaved 30mL beaker to at least 60
degrees Celsius, cover with Kimwipe while heating to reduce contamination. Reduce
heat to prevent boiling.
3. Add appropriate measurements of gelatin** using sterile scoop:
→ For 5% gelatin solution, add .5g 300 Bloom Type A gelatin* to 10 mL of
heated sterile Milli Q water.
→ For 7% gelatin solution, add .7g 300 Bloom Type A gelatin* to 10 mL of
heated sterile Milli Q water.
* cover with Kimwipe until ready to put into solution
** adjust amount of gelatin/water per need
4. Stir until solution is homogeneous, using a stir bar, and move into the hood (use
ethanol soaked Kimwipe to wipe outside of beaker, DO NOT spray beaker).
5. Using sterile pipette tips without filters, pipette the appropriate amount of gelatin
solution into each area.
6. When pipetting out the solution:
 Cast one section at a time, gelatin can dry out and solidify quickly.
 When sucking up the gelatin solution, make sure you only push down to the
first stop on the plunger.
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7.
8.

9.

10.
11.

When dispensing, make sure to not push down on the plunger after the first
stop point (even if you have a small amount of solution left) or else you will
create bubbles in your film on your casting block.
 Gently spread your film along the edges of the masking tape. You do not need
to use a lot, just ensure the gelatin will have something to stick to while it is
drying.
 Try to move bubbles out of the casted area and on the masking tape so there is
a smooth surface. Use a new pipette tip if you need to suck off bubbles.
 Pipette solution as evenly as possible over section so that it will be less likely
to tear when removing (once dry).
 Use a new non-filtered pipette tip for each casted segment.
Let dry overnight in hood.
Carefully remove the gelatin sheets from the plate by removing most of the tape.
Tweezers may be used as an aid. Concentrate on removing one film at a time and be
careful not to tear films. Keep trash tape in hood until completely finished with
removing all films to minimize going in and out of the hood.
Place the sheets in a sterile Petri dish and label with:
Your initials
The date
Sheet size
Gelatin concentration
Remove the casting block from the hood and remove any tape residue from the plate.
Wash all lab supplies with Alconox and water. Dry completely before autoclaving.
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Protocol for Rolling Gelatin Tubes
Materials:
Petri Dish
Sterile Autoclaved Milli Q water
Teflon rod
Valve pieces
Method:
All steps must be done inside the sterile hood.
*** Make sure to ethanol your gloves and wipe down anything you put inside the hood with
a Kimwipe soaked in ethanol.
12. Pour sterile Milli Q water into a sterile Petri dish, until about 2/3 full.
13. Assemble rod and valve apparatus (as seen below) and set aside.
14. Place dehydrated gelatin film in the sterile Milli Q water for a few seconds to
rehydrate (make sure to saturate whole sheet).
15. Using sterile forceps and/or sterile gloves, gently remove the film from the water and
carefully wrap it around the Teflon mandrel and valve apparatus.
**The film will be very fragile until it is treated with glutaraldehyde, so be careful.
16. Make sure to align the end of the films to edge of the grooved sections closest to the
valve. You may need to adjust the distance of the valve pieces to accommodate the
length of the gelatin film.
17. Wrap the film tightly and neatly around the mandrel/rod in order to eliminate any air
bubbles. Try to avoid too much overlap and wrinkles in the tube. Try to keep the
rod/valve apparatus as dry as possible, doing that will aid in the sheet sticking easier.
18. You may need to keep your glove tips moistened to prevent your gloves from
sticking to the sheet.
19. If film tears or rips, dispose of the gelatin film and start process over with a new film
and Teflon apparatus.
20. When tube rolling is complete, let the tube dry completely (in sterile Falcon tube or
on autoclaved plastic casting block) before starting the glutaraldehyde treatment
process.
21. Make sure to label tube or plate(w/ tape) with:
Your initials
The date
Gelatin %
Untreated
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Protocol for Glutaraldehyde Treatment of Gelatin Tubes
*** Lab coat and gloves required for entire treatment process!!!
Wear closed toed shoes and pants.
Materials:
25% Glutaraldehyde (Sigma G6257-100mL)
Glycine (Sigma G8790-100mg)
Sterile Milli Q water
Petri dishes
Sterile Serological Pipettes
Agitator
Aspirator
Sterile, Autoclaved Media Bottles
Stock Solution Prep: (Mixing should occur in sterile hood)
1. Prepare a solution of 1% Glycine in a sterile autoclaved 250mL media bottle.
2. Measure 1g of Glycine in a weigh boat. Place in hood and add to sterile media bottle.
3. Add 100mL of PBS using sterile serological pipette to media bottle, pipette up and
down to mix.
4. Prepare a 2.5% solution of Glutaraldehyde in a sterile autoclaved 250mL media
bottle.
5. Use sterile 25mL serological pipette to add 25mL of 25% Glutaraldehyde to sterile
media bottle. Dispose of pipette.
6. Use a new sterile serological pipette to add 225mL of sterile Milli Q water to media
bottle. Pipette up and down to mix.
Method: (Entire treatment occurs in sterile hood)
***Ethanol your gloves and wipe down hood with ethanol before introducing anything into
hood. Wipe down anything that you put in the hood with a Kimwipe soaked in ethanol.
22. Once rolled tubes are dry, place in a sterile 15mL Falcon tube.
23. Place 1 autoclaved 250 mL beaker in hood and label 0.1% (or 0.3%) Glutaraldehyde
with tape.
24. Prepare 120 mL solution of 0.1% (or 0.3%) Glutaraldehyde for treatment of 10 tubes.
25. Using a sterile 5 mL serological pipette, add 4.8 mL (or 14.4 mL for 0.3%) of 2.5%
Glutaraldehyde to beaker. Dispose of pipette.
26. Add 95.2 mL (or 105.6 mL for 0.3%) of sterile Milli Q water to beaker with a sterile
25mL serological pipette. Once all water is added, pipette solution in beaker up and
down to mix. Dispose of pipette.
27. Add 11-12 mL of 0.1% (or 0.3%) Glutaraldehyde to each falcon tube with a sterile
10mL serological pipette (add enough to completely cover gelatin tube and top
valve). To ensure adequate crosslinking, leave the glutaraldehyde in the Falcon tube
for 20 minutes.
28. Fill 3 autoclaved 50 mL graduated cylanders with Milli Q water.
29. Aspirate glutaraldehyde and dip into three vials of water in succession to rinse the
teflon parts and tube. After every 3 gelatin tubes, dump water and fill with fresh
sterile Milli Q water.
30. Fill Falcon tubes with sterile Milli Q water using a sterile 25mL serological pipette.
Put enough water to completely cover gelatin tube and top valve. Dispose of pipette.
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31.
32.

33.
34.

35.
36.
37.

38.
39.

Once all of the Falcon tubes have water in them, tape entire Falcon tube holder to
pipettor battery to agitate all 10 tubes at the same time.
Leave to rinse under agitation for 3 hours.
Aspirate off the water and fill falcon tubes with 1% Glycine using a sterile 25 mL
serological pipette. Dispose of pipette. Once all of the Falcon tubes have water in
them, tape entire Falcon tube holder to pipettor battery to agitate all 10 tubes at the
same time.
Leave to rinse under agitation for 2 hours.
Aspirate off the Glycine and fill Falcon tubes with sterile Milli Q water with a sterile
25 mL serological pipette. Dispose of pipette once all tubes are completed. Once all
of the Falcon tubes have water in them, tape entire Falcon tube holder to pipettor
battery to agitate all 10 tubes at the same time.
Leave to rinse under agitation for 1 hour.
Repeat steps 13 and 14 twice with fresh sterile Milli Q H2O. (Tubes should rinse for a
total of 3 hours in sterile Milli Q water).
After the final treatment step, let the tubes dry completely in the hood before
removing the Teflon mandrel/rod. To do this, remove tubes from falcon tube and
place on an autoclaved block (the ones used for making the gelatin sheets).
Once dry (12-24 hours), remove Teflon rod carefully. Place completed gelatin tubes
in a sterile bag.
Make sure to label the bag 0.1% (or 0.3%) GA in addition to the concentration of
gelatin, initials and date.
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Protocol for Initial Bioreactor Assembly
*** Done outside of sterile hood
Parts List:
1—50 mL Falcon Tube
4—1/8” ID to Male Luer Lock Converters
4—Female Luer Lock Caps
1—1/8” ID Valved Snap Lock Assembly
1—1/8” ID Non-Valved Snap Lock Assembly (including nut)
1—1/4” OD Tube Clamp
7”—1/8” ID PVC tubing
Quick Setting Gel Epoxy (Temperature use range of up to 300 degrees F)
Tools List:
Power Drill with 1/2”, 1/4”, 1/8”, 1/16” bits
Razor Blade
Sand Paper
Ruler
Nitrile Gloves
Permanent Marker
Autoclave
Procedure:
1) Using a 1/8” bit on the power drill, drill two holes in the Falcon Tube body in the
locations indicated on the drawing below. Take care not to drill the opposite side of the
tube when the bit pierces the wall. Sand all rough edges and surfaces bordering the holes.

2) Using a 1/4” bit, drill a hole at the tip of the conical section of the Falcon Tube as
indicated in the drawing above.
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3) Remove the lid from the Falcon Tube and drill 1 hole in the center of the lid using the
1/2” bit. (See the drawing below for hole location.) Sand all rough edges.

4) Using the 1/16” bit on the power drill, drill 6 holes in the lid in the locations indicated on
the drawing provided. Sand all rough edges. Set the Falcon Tube and lid aside.
5) Measure out and use the razor blade to cut a 6” segment and a 1” segment of PVC tubing
and set aside.
6) Take two 1/8” ID to male luer lock converters and roughen all surfaces on the barbed end
with sand paper (see picture below.)

7) Take the valved snap lock assembly and use a razor blade to remove the plastic
surrounding the lock release until the plastic is flush with the natural curve of the
component (see picture below.)
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8) Insert the 6” segment of tubing into the hole at the tip of the conical section of the Falcon
Tube and feed this tubing as far as possible without pulling the tubing out of the hole.
9) Insert a valved snap lock assembly into the end of the tubing that was fed into the Falcon
Tube (see picture below.)

10) Run the opposite end of the 6” segment of tubing through a tube clamp so that the
locking mechanism faces toward the tip of the conical section of the Falcon Tube (see
picture below.)

11) Insert a 1/8” ID to male luer lock converter into the open end of the 6” segment of
tubing.
12) Wear nitrile gloves and cover the work space with aluminum foil. Then, mix a small
amount of the gel epoxy in weigh boat or other appropriate container.
13) (CAUTION: this step must be done quickly and carefully. Epoxy hardens in 5 min and
becomes extremely hot in the process. DO NOT TOUCH WITH BARE HANDS) apply
a small amount of epoxy to the barbed end of each 1/8” ID to male luer lock converter
and immediately force fit the converter into the two remaining 1/8” holes on the Falcon
Tube taking care not to obstruct the path of flow through the converter with epoxy (see
picture below.) Set aside to dry for 1 hour.
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14) Take the remaining 1” segment of tubing and place a 1/8” ID to male luer lock converter
in one end and the non-valved snap lock assembly in the other end (see picture below.)

15) Remove the nut from the snap lock assembly and insert the threaded end of the snap lock
assembly through the 1/2” hole in the Falcon Tube lid such that the tubing is on top of the
lid. Replace the nut and screw on just enough for it to remain on the threading (see
picture below.)

The following steps are only to be performed after the epoxy has been allowed to dry for at
least one hour
16) Remove the 2 male components of the 2 snap locks by pressing the button on the side of
each snap lock assembly. Set the male component aside for use in gelatin tube casting.
17) Attach 4 female luer lock caps to all 4 exposed male luer lock fittings.
18) Rinse all parts with Alconox and Milli Q water. Allow to dry completely.
19) Arrange the bioreactor as shown below. Be sure to feed the 6” tubing segment as far into
the Falcon Tube as the lid will allow. Also, ensure that both of the snap clips are engaged
(button pressed in and locked in the open position) and that the tube clamp is open.
Finally, check that the nut on the lid assembly is as high as possible on the threading (see
picture below.)

20) Using a permanent marker place a tick mark on the white field of the Falcon Tube body
to indicate that this bioreactor has undergone a sterilization cycle.
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The following steps are only to be performed after the epoxy has been allowed to completely
cure for 24 hours
21) Autoclave the pouch according to the parameters outlined in the Bioreactor Sterilization
Protocol.
22) Repeat steps 1-21 for each bioreactor
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Protocol for Bioreactor Sterilization
Preparation
1. Wash bioreactor assembly with water and alconox and allow to air dry. Then rinse
with MilliQ water and allow to air dry again.
2. Ensure that the autoclave has enough water in it and that weekly maintenance has
been performed as scheduled.
Procedure
1. Ensure that the natural curvature of the tubing and the tube clamp are in the same
plane as the two outside ports of the bioreactor body to avoid any unnecessary stress
on the tubing and/or the two outside ports.
2. Place two bioreactors in a sterilization pouch so that they are touching as little as
possible. (See picture below.) Remove the adhesive strip and close the bag, ensuring
a complete seal.

3. Place the sterilization pouch on an autoclave tray with the clear blue side facing up.
Place a maximum of two trays in the autoclave such that the clear blue side of the
sterilization pouches is not allowed to touch any metal surfaces.
4. Close and lock the autoclave.
5. Press the button marked “1” and ensure that the display reads the following
parameters:
• Temperature: 250˚F/121˚C
• Pressure: 15 psi/104 kPa
• Duration: 15 min
• Dry Method: Fast Vent
• Dry Time: 30 min
6. Press start. The autoclave will heat up, perform the programmed cycle, then
automatically open slightly for the 30 min dry time. Do not remove the pouches until
this dry time has completed.
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7. After the 30 min dry time has completed, open the autoclave door and remove the
pouches
8. Allow the pouches to sit, clear blue side facing up, for a minimum of 1 hour and 30
min before attempting to use the bioreactors for any application.
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Protocol for Assembling Bioreactor in Preparation of Cell Seeding
Preparation
1. Ensure all components, tools, and materials have been autoclaved in sterilization
pouches.
2. Clean assembly area in the sterile hood with ethanol.
3. Wipe down all sterilization pouches and other material packaging with ethanol.
4. Place bioreactors, gelatin tubes, falcon tube rack(s), forceps, and sterile gloves in
the sterile hood.
Assembly (requires 2 people—denoted (1) & (2))
1. (1) & (2)—Open a pair of appropriately sized sterile gloves taking care not to
touch the inside of the packaging or the outside of the gloves while placing them
on your hands.
2. (1)—Open the sterilization pouch containing the falcon tube rack, remove the rack,
and place it on the sterile hood table.
3. (1)—Open the sterilization pouch containing the forceps without touching the
inside of the pouch and set the pouch aside.

4. (1)—Open the sterilization pouch containing a bioreactor without touching the
inside of the pouch.
5. (2)—Reach into this pouch and remove the bioreactor assembly. Unscrew the lid
of the assembly and set aside.
6. (1)—Open sterile bag containing the gelatin tubes and hold open for (2).
7. (2)—Use curved forceps to hold the female snap connector attached to the
bioreactor body.
8. (2)—Use the straight forceps to remove the gelatin tube from the open falcon tube
by grabbing it by the valved male snap connector.

9. (2)—Snap the male valved snap connector into the female snap connector by
pressing with your index finger on the pivot point of the straight forceps until the
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snap of the locking mechanism is heard (take care not to touch the inside of the
bioreactor or any part of the gelatin tube assembly with anything other than the
forceps). *use hand as a last resort*
10. (2)—Pull the tube attached to the female snap connector until the bottom of the
non-valved male snap connector is even with the top of the bioreactor body.

11. (2)—Place the straight forceps across the rim of the opening at the top of the
bioreactor body and squeeze them such that they support the non-valved male
snap connector but do not touch the gelatin tube.
12. (2)—Take the bioreactor lid and snap the non-valved male snap connector into the
female snap connector on the lid by pressing the lid firmly down onto the nonvalved male snap connector until the snap of the locking mechanism is heard.

13. (2)—Pull on the tube attached to the female snap connector associated with the
bioreactor body until the lid reaches the opening at the top of the bioreactor body.
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14. (2)—Screw on the bioreactor lid (not too tight) taking care not to twist the gelatin
tube.
15. (2)—Screw down the nut above the lid until it is just tight.

16. (2)—Slide the tube clamp as high as the bioreactor body will allow.

17. (1 & 2)—Repeat steps 2-18 for each bioreactor, set aside in sterile hood until
ready to start cell seeding process.

50

Protocol for Bioreactor Cell Seeding
Preparation
5. Clean surfaces in sterile hood with ethanol.
6. Wipe down all materials with ethanol and place in sterile hood.
7. Ensure pre-made bioreactors (w/ gelatin tubes), and sterile gloves are in the sterile
hood.
Assembly (requires 2 people—denoted (1) & (2))
1. (1) & (2)—Open a pair of appropriately sized sterile gloves taking care not to touch
the inside of the packaging or the outside of the gloves while placing them on your
hands.
2. (1)—Unscrew the luer lock cap on top of the tubing that leads to the gelatin tube and
set the cap, on the sterile hood table.
3. (2)—Loosen the lid of the falcon tube containing the cells (see protocol for counting
cells below). Also, open a sterile 3 mL syringe (making sure to screw off the needle).
4. (2)—Make sure to pipette solution up and down during procedure so that cells don’t
settle/bind to inside of tube.
5. (2)—Fill the syringe with the cell/media mixture and screw
the syringe into the open (top) luer lock fitting.
6. (1)&(2)—(1)Remove the luer lock cap on the end of the 6”
length of tubing to allow for flow while (2) injects cells
until they line the entire length of the gelatin tube and
close the tube clamp to ensure flow is stopped. Make sure
not to push the plunger down once clamp is closed, it will
cause the gelatin tube to leak. Replace both luer lock caps.

7. (1)— Unscrew the upper luer lock cap (on the bioreactor
body).
8. (2)—Open a new 50 mL syringe and fill with ~40 mL of
media without touching the inside of the media bottle
with the outside of the syringe.
9. (2)—Screw the syringe into the open luer lock and inject
the media until it is flush with the bottom of the open
luer lock fitting (as illustrated by the red line).
10. (2)—Remove the syringe and replace the luer lock cap.
11. (1)&(2)—Repeat steps 2-10 for each bioreactor.
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Cell Counting (using a hemacytometer) Procedure: done in conjunction with above
Materials:
- Hemacytometer
- Cell counter/tally clicker
- Cell culture reagents: media, PBS, Trypsin
1. Prepare hemacytometer by wiping with lens paper and ethanol. Also prepare a
coverslip the same way, and place on the counting surface prior to adding cell
suspension.
2. Prepare cells (on a tissue culturing plate) by first aspirating off media, rinsing cells
with 2-3 mL PBS, and aspirating that off.
3. Next add 2-3 mL Trypsin and place in incubator ~ 5 minutes. After the 5 minutes,
ensure cells have come off of the plate by slightly tapping the side. DO NOT
aspirate off this mixture (the Trypsin will be diluted out).
4. Once cells are ready, add ~ 10mL media. Pipette up and down to mix and place
mixture in a 15 mL falcon tube.
5. Centrifuge at 2000rpm for 2 minutes.
6. Aspirate most of media, making sure not to disturb pellet. Add appropriate amount
of media to tube and resuspend cells carefully.
7. Remove 10 uL of cell mixture, pipetting into one of the V-shaped wells of the
hemacytometer. Allow mixture to flow through slide by capillary action.
Counting:
- Make sure most of grid is in focus with the 4x objective (40x magnification).
- Count cells in the larger squares of the four corners, plus the large middle
square. Each of the large 9 squares has a volume of 0.1mm3(or 10-4 cm3,
1cm3=1 mL). A total of count of around 100 cells is needed for it to be
statistically significant.
- Once the count is completed, the calculation process can be seen below:
# of cells/0.5mm3 * = cells/mm3
(cells/mm3) x 1000 = cells/mL
(* volume of big square x # of squares)
Sample calculation:
125cells/0.5mm3 = 250 cells/mm3
(250 cells/mm3) x 1000 ** = 250,000cells/mL
(** conversion factor between mm3 and cm3)
A cell count should be conducted before each
cell seeding. The cell solution made need to be
diluted to the same cell number for accurate results.
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Bioreactor Media Protocol
Preparation
1. Clean table in the sterile hood with ethanol
2. Wipe down all material packaging and media lid with ethanol
3. Place sterile gloves, bioreactors in falcon tube rack(s), and media in the sterile
hood
Procedure
1. Open a pair of appropriately sized sterile gloves taking care not to touch the inside
of the packaging or the outside of the gloves while placing them on your hands
2. Place a sterile 250 mL beaker underneath the bottom luer lock assembly on the
bioreactor body
3. Remove the bottom luer lock cap on the bioreactor body allowing the media to
drain into the 250 mL beaker below until all media is removed from the
bioreactor. See picture below. Replace the luer lock cap.

4. Remove the top luer lock cap on the bioreactor body, placing the cap, top down,
on the sterile hood table
5. Open the media bottle and a new 50 mL syringe
6. Fill the syringe with media taking care not to touch the inside of the media bottle
with the outside of the syringe
7. Take the media filled syringe and screw it into the open luer lock fitting

53

8. Inject the media into the bioreactor body until the media level is flush with the
bottom of the luer lock through which the media is being delivered
9. Unscrew the syringe from the top luer lock and replace the luer lock cap
10. Repeat steps 2-9 for all bioreactors, refilling the syringe as necessary to deliver
the appropriate amount of media
11. Place the rack of bioreactors back in the incubator
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Protocol for Plating, Splitting/Passaging, and Freezing of Cells
Plating Cells
Materials:
Water bath (at 400C)
Transfer pipettes
Falcon tubes (50 mL)
Petri dishes (10 cm)
Growth Media
Method:
All steps, except #1 should be done in sterile hood.
1. Remove cryo vial containing cells from liquid nitrogen in cryo-tank and thaw in 400C
water. Use CAUTION: the transition from -1730C to +400C can result in explosion
due to rapid gas expansion
2. Transfer cells from cryo vial into the appropriate final volume of growth media
3. Pipette up and down to mix
4. Transfer the appropriate volume of cell suspension into each new plate and place in
the incubator

Splitting/Passaging Cells (10cm plate)
Materials:
Aspirator
Pipette tips
Transfer pipettes
1000uL pipette
Falcon tubes (50 mL)
Petri dishes (10 cm)

PBS
Trypsin
Growth Media

Method:
All steps should be done in sterile hood.
1. Aspirate media, use a new pipette tip for every dish
2. Rinse culture dish with 3-4mL PBS and aspirate
3. Apply 1.5mL trypsin solution to culture dish and place back in the incubator
4. Check frequently to assess cell detachment, tap side of dish to assist detachment
5. When cells detach, remove them from the dish with a 1000uL pipette and place in a
new volume of growth media (10mL per new plate)
6. Pipette up and down to mix (using transfer pipettes)
7. Replace cells by pipetting 10mL of the new cell suspension into each new 10cm2
culture dish and place in incubator
****NOTE: Cells will need to be “fed” by changing growth media roughly every 2-3
days. Media will be an orange-like color.
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Freezing Cells
Materials:
Aspirator
Pipette tips
Transfer pipettes
1000uL pipette
Falcon tubes (15 mL)
Cryo-vials

PBS
Trypsin
Growth Media
Cell Freezing Media

Method:
All steps should be done in sterile hood.
1. Aspirate media, use a new pipette tip for every dish
2. Rinse culture dish with 3-4mL PBS and aspirate
3. Apply 1.5mL trypsin solution to culture dish and place back in the incubator
4. Check frequently to assess cell detachment, tap side of dish to assist detachment
5. When cells are detached, place them in a small volume (5-10mL) of media in a 15mL
tube (the extra growth media will inactivate most of the trypsin).
6. Centrifuge cells for 10 minutes at 500 x g at 40C to form a pellet.
7. Carefully pipette the majority of the liquid off.
8. Resuspend the cell pellet in more growth media, carefully pipette up and down to
mix.
9. Centrifuge cells for 10 minutes at 500 x g at 40C to form a pellet (this rinse removes
the trypsin from the cells).
10. Carefully pipette the majority of the liquid off.
11. Resuspend the cell pellet in the appropriate volume of cell freezing media, carefully
pipette up and down to mix and aliquot to cryo-vials.
12. Place in vials in -800C freezer overnight, then into liquid nitrogen storage.
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Protocol for Cell Media Preparation
**Make only as much as you need for 2 weeks at the most, numbers below need to be
modified if more or less than 500mL is needed.
Materials:
Dulbecco’s Modified Eagle’s Medium (Sigma D6434)
L-Glutamine (Fluka 49420-100g)
Insulin (CR1505A-25mg)
Fetal Bovine Serum (Invitrogen 16250-078 500mL)
Antibiotics (penicillin and streptomycin)
Outside of Hood:
1. Weigh out .25g L-Glutamine using a sterile scoop and mix with 5mL of Dulbecco’s
Modified Eagle’s Medium.
Inside Hood:
2. Once in solution, suck up L-Glutamine with a sterile syringe and filter (using syringe
filter, Fisher 09-719A) into a sterile media bottle with sterile side of filter touching
top of media bottle.
** When using syringe and filter unit: fill the syringe with solution to filter, remove the
cover from the filter unit, attach the syringe to the filter unit & remove from package,
hold the syringe with filter pointing up and top it off by pushing a few drops thru (do
NOT touch underside of filter unit – will contaminate), make sure to have the sterile side
of filter touching top of media bottle while injecting the solution.
3. Add 440mL of sterile Dulbecco’s Modified Eagle’s Medium (Sigma D6434) with a
sterile serological pipette.
4. Add 0.25mL of 10mg/mL insulin to media bottle with filtered pipette tip. (Final
concentration must always be .005mg/mL for any volume of media).
5. Add 50mL of Fetal Bovine Serum with a sterile serological pipette.
6. Add 5mL of antibiotics (penicillin and streptomycin) with filtered pipette tip.
7. Pipette up and down to mix with a sterile serological pipette.
***Make sure to label bottle appropriately and clearly:
DMEM
10% FBS
1% antibiotics (pen + strep)
5 µg/mL insulin
your initials
the date of preparation
“USE BY” date (2 weeks from date above)

***Store in refrigerator, media solution lasts approximately 2 weeks.
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Appendix B: Additional Images of Cells
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